Does prompt invasive coronary angiography and revascularization reduce mortality in patients with acute coronary syndromes?
Prompt invasive evaluation and revascularization are critical for reducing mortality in patients presenting with STEMI or high-risk NSTE-ACS.
Each year, an estimated more than 7 million people are diagnosed with ACS worldwide. For patients with STEMI, coronary catheterization and PCI within 2 hours of presentation reduces mortality, with fibrinolytic therapy reserved for patients without access to immediate PCI. For high-risk patients with NSTE-ACS without contraindications, prompt invasive coronary angiography followed by percutaneous or surgical revascularization is associated with lower rates of death.
Bhatt et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: